ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 NGS Genetic DNA Test
Introduction
The ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 NGS Genetic DNA Test is a cutting-edge diagnostic tool that plays a crucial role in identifying genetic factors associated with neurological disorders. This test employs Next-Generation Sequencing (NGS) technology, allowing for a comprehensive analysis of the ATP1A2 gene, which is linked to alternating hemiplegia of childhood—a rare neurological condition characterized by recurrent episodes of hemiplegia.
What the Test Measures
This genetic test detects mutations in the ATP1A2 gene, which can lead to the development of alternating hemiplegia. By analyzing the gene’s structure, we can determine if there are any abnormalities that may contribute to the symptoms experienced by the patient.
Who Should Consider This Test?
Individuals who exhibit symptoms such as recurrent episodes of weakness or paralysis, particularly in one side of the body, should consider this test. Additionally, those with a family history of neurological disorders may benefit from testing, as understanding genetic predispositions can guide treatment and management options.
Benefits of Taking the Test
- Early and accurate diagnosis of alternating hemiplegia of childhood.
- Informed decision-making regarding treatment options.
- Understanding the genetic basis of symptoms can aid in family planning.
- Access to genetic counseling for better management of the condition.
Understanding Your Results
Upon receiving your results, it is essential to consult with a healthcare professional, preferably a neurologist or genetic counselor, who can provide insights into the findings. They will help interpret the results, discuss potential implications, and outline the next steps.
Test Details and Pricing
Test Name | Discount Price | Regular Price |
---|---|---|
ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for this test can be blood or extracted DNA, or even one drop of blood on an FTA card. Prior to testing, a clinical history of the patient is necessary, and a genetic counseling session is recommended to draw a pedigree chart of family members affected by the condition.
Book Your Test Today!
We have branches across Kenya, making it convenient for you to access our services. To book the ATP1A2 Gene Alternating Hemiplegia of Childhood Type 1 NGS Genetic DNA Test, please call or WhatsApp us at +254711564616. Take the first step towards understanding your health today!